
Opinion|Videos|November 4, 2024
Community Oncologist Perspective: Evaluating, Identifying, and Managing CRS
Dr Graff discusses the recommendations for evaluating, identifying, and managing cytokine release syndrome (CRS), covering the pretreatment phase, patient education, treatment location, premedications, CRS management, dose modifications, and the community oncology perspective.
Advertisement
Video content above is prompted by the following:
- What are the recommendations for evaluating, identifying, and managing cytokine release syndrome (CRS)?
- Pretreatment phase
- Patient education and monitoring
- Treatment location
- Premedications
- Management of CRS
- Dose modifications and retreatment
- Community oncology perspective
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Blinatumomab Plus Chemo Show Improved Survival in Infants with KMT2A-r ALL
2
NCCN Updates Breast Cancer Guidelines: Sacituzumab Govitecan for 1L TNBC
3
Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment
4
Bria-IMT Shows Extended Survival in Advanced Metastatic Breast Cancer
5
















